WASHINGTON (AP) — Responding to outcries from medical experts, Food and Drug Administration Commissioner Stephen Hahn is admitting he overstated the life-saving benefits of treating COVID-19 patients with convalescent plasma.
Medical experts have been pushing back against the claims about the treatment since President Donald Trump’s announcement on Sunday that the FDA had decided to issue emergency authorization for convalescent plasma.
Trump hailed the decision as a historic breakthrough even though the treatment’s value has not been established.
The announcement on the eve of Trump’s Republican National Convention raised suspicions that it was politically motivated to offset critics of the president’s handling of the pandemic.